Summary from the original article
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
By Berkeley Lovelace Jr. ·
AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.
Upgrade this serverThe Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
2 days ago · nbcnews.com · You are reading this one
The Hill · 2 days ago
FDA warns of rare ‘eye stroke’ risk from GLP-1 drugsCNBC · 2 days ago
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepboundthenationalherald.com · 2 days ago
FDA Adds Rare Vision-Loss Warning to Popular GLP-1 Drugs
